These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7150322)

  • 1. Regulation of glycophorin of complement activation via the alternative pathway.
    Okada N; Yasuda T; Tsumita T; Shinomiya H; Utsumi S; Okada H
    Biochem Biophys Res Commun; 1982 Sep; 108(2):770-5. PubMed ID: 7150322
    [No Abstract]   [Full Text] [Related]  

  • 2. Species-specific inhibition by glycophorins of complement activation via the alternative pathway.
    Okada H; Tanaka H
    Mol Immunol; 1983 Nov; 20(11):1233-6. PubMed ID: 6656770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction of alternative complement pathway activation by sialosylglycolipids.
    Okada N; Yasuda T; Okada H
    Nature; 1982 Sep; 299(5880):261-3. PubMed ID: 7110347
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of human glycophorin A and saccharides on the invasion of human erythrocytes by Plasmodium falciparum].
    Li JX; Zhou YC; Wei YM
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1986; 4(2):86-9. PubMed ID: 3533309
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the alternative complement pathway of guinea-gip by liposomes incorporated with trinitrophenylated phosphatidylethanolamine.
    Okada N; Yasuda T; Tsumita T; Okada H
    Immunology; 1982 Jan; 45(1):115-24. PubMed ID: 6173312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus).
    Ourth DD; Bachinski LM
    Dev Comp Immunol; 1987; 11(3):551-64. PubMed ID: 3678558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.
    Michalek MT; Mold C; Bremer EG
    J Immunol; 1988 Mar; 140(5):1588-94. PubMed ID: 3346543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the interaction of HVJ (Sendai Virus) with liposomal membranes. HVJ-induced permeability increase of liposomes containing glycophorin.
    Oku N; Nojima S; Inoue K
    Virology; 1982 Jan; 116(2):419-27. PubMed ID: 6278721
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 11. Autosomal locus regulates inverse relationship between sialic acid content and capacity of mouse erythrocytes to activate human alternative complement pathway.
    Nydegger UE; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Dec; 75(12):6078-82. PubMed ID: 282625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glycolipids and glycophorin on the activity of human interferon-beta and -gamma.
    Fuse A; Handa S; Kuwata T
    Antiviral Res; 1982 Aug; 2(3):161-6. PubMed ID: 6814359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycophorin A interferes in the agglutination of human erythrocytes by concanavalin A. Explanation of the requirement for enzymic predigestion.
    Gokhale SM; Mehta NG
    Biochem J; 1987 Jan; 241(2):505-11. PubMed ID: 3297033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
    Okada N; Yasuda T; Okada H
    J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycophorin-induced differentiation of human myelogenous leukemic cell lines.
    Murayama J; Sakagami H; Takeda M
    Anticancer Res; 1997; 17(4A):2545-8. PubMed ID: 9252678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdlan, a (1----3)-beta-D-glucan from Alcaligenes faecalis var. myxogenes IFO13140, activates the alternative complement pathway by heat treatment.
    Matsushita M
    Immunol Lett; 1990 Oct; 26(1):95-7. PubMed ID: 2276766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation.
    Okada N; Yasuda T; Okada H
    Biochem Biophys Res Commun; 1988 Mar; 151(2):743-8. PubMed ID: 3348808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of phagocytosis by erythrocyte membrane sialoglycoprotein on target liposomes.
    Utsumi S; Shinomiya H; Minami J; Sonoda S
    Immunology; 1983 May; 49(1):113-20. PubMed ID: 6840799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.